{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:17:44Z","timestamp":1780571864978,"version":"3.54.1"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473523"],"award-info":[{"award-number":["82473523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shanghai","award":["23ZR1408600"],"award-info":[{"award-number":["23ZR1408600"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC22025306"],"award-info":[{"award-number":["SHDC22025306"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vitiligo fluctuates between progressive and quiescent states, complicating decisions about when to intervene, how to select therapy and how to monitor response. In this review, we integrate bedside phenotypes with multilevel molecular readouts to summarize emerging evidence linking clinical signs and biologic signals to disease activity and treatment response in clinical studies. For staging, tool-free and standardized assessments such as Koebner phenomenon, confetti-like depigmentation, Wood\u2019s lamp and dermoscopy provide visible clues associated with active disease. Measurements from blood, suction blister fluid and tissue offer complementary insights into local and systemic immune activation, suggesting how molecular signals may relate to progression. For stratification, factors such as age, lesion site, disease stability, comorbidities and dermoscopic border features have been tentatively associated with differential responses to therapies such as phototherapy or transplantation. Similarly, lower baseline levels of inflammatory, chemotactic and cytotoxic markers have been informally aligned with better outcomes in clinical studies. For monitoring, the response phase typically mirrors a reversal of progression: waning inflammatory signalling, reduced effector-cell burden and partial recovery of melanogenic programmes provide molecular parallels to clinical improvement. Across these domains, the interferon-\u03b3\u2013CXCL9\/CXCL10\u2013CD8+ T-cell axis emerges as the most recurrent immune signature, demonstrating reproducible associations with activity, prognosis and treatment response. Future work should prioritize harmonized definitions of disease activity, standardized sampling standards and multicentre validation of integrated biomarker panels. It is equally critical to determine whether proposed biomarker thresholds relate to clinically meaningful endpoints, thereby translating early-stage discoveries into reliable frameworks for staging, stratification and monitoring.<\/jats:p>","DOI":"10.1093\/bjd\/ljag058","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T12:35:11Z","timestamp":1771158911000},"page":"1006-1023","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and molecular markers of vitiligo: a narrative review of early-stage insights into disease activity and\u00a0treatment response"],"prefix":"10.1093","volume":"194","author":[{"given":"Zhe","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8410-667X","authenticated-orcid":false,"given":"Yijian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Xuan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-0817","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-3962","authenticated-orcid":false,"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-5667","authenticated-orcid":false,"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University , Shanghai ,","place":["PR China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2026051911001200200_ljag058-B1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CCID.S506426","article-title":"Correlation between the Koebner phenomenon and clinical features in vitiligo","volume":"18","author":"Tang","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026051911001200200_ljag058-B2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jdv.15604","article-title":"Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis","volume":"33","author":"van Geel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026051911001200200_ljag058-B3","doi-asserted-by":"crossref","first-page":"e70044","DOI":"10.1111\/pcmr.70044","article-title":"Clinical prognostic factors predicting outcomes in vitiligo: a scoping review","volume":"38","author":"Kumari","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2026051911001200200_ljag058-B5","doi-asserted-by":"crossref","first-page":"1387011","DOI":"10.3389\/fimmu.2024.1387011","article-title":"Proteomics data in vitiligo: a scoping review","volume":"15","author":"Berrevoet","year":"2024","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2015.05.014","article-title":"Confetti-like depigmentation: a potential sign of rapidly progressing vitiligo","volume":"73","author":"Sosa","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40257-012-0001-9","article-title":"Depigmentation patterns of nonsegmental vitiligo: a prospective study of macromorphologic changes in lesions","volume":"14","author":"Menchini","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"2026051911001200200_ljag058-B9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(00)90170-1","article-title":"Clinical and histopathologic characteristics of trichrome vitiligo","volume":"42","author":"Hann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjd.12034","article-title":"Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo","volume":"168","author":"Benzekri","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaad.2016.12.040","article-title":"Clinical markers of vitiligo activity","volume":"76","author":"Benzekri","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B12","doi-asserted-by":"crossref","first-page":"e13223","DOI":"10.1111\/pcmr.13223","article-title":"Sensory symptoms as an early manifestation of active vitiligo: a case\u2013control clinical and molecular study","volume":"38","author":"Sayed H","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B13","doi-asserted-by":"crossref","first-page":"5617838","DOI":"10.1155\/2017\/5617838","article-title":"Prevalence and clinical characteristics of itch in vitiligo and its clinical significance","volume":"2017","author":"Vachiramon","year":"2017","journal-title":"Biomed Res Int"},{"key":"2026051911001200200_ljag058-B14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20785","article-title":"Clinical heterogeneity in vitiligo: identification of clinical markers based patient clusters","author":"Galissi","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026051911001200200_ljag058-B15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamadermatol.2019.4483","article-title":"Association of clinical markers with disease progression in patients with vitiligo from China","volume":"156","author":"Zhang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2026051911001200200_ljag058-B16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/13813455.2020.1739717","article-title":"Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case\u2013control study)","volume":"128","author":"Shabaka","year":"2022","journal-title":"Arch Physiol Biochem"},{"key":"2026051911001200200_ljag058-B17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jdv.18134","article-title":"Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)","volume":"36","author":"van Geel","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026051911001200200_ljag058-B18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.13432","article-title":"Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo","volume":"172","author":"Komen","year":"2015","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bjd.18950","article-title":"Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)","volume":"183","author":"van Geel","year":"2020","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/jocd.16145","article-title":"In-depth study of Wood's lamp examination combined with reflective confocal laser scanning microscopy for the guidance of vitiligo staging and treatment","volume":"23","author":"Hou","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"2026051911001200200_ljag058-B21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4103\/idoj.idoj_728_24","article-title":"Comparison of dermoscopy and Wood's lamp in the assessment of stability of vitiligo","volume":"16","author":"Mohan","year":"2025","journal-title":"Indian Dermatol Online J"},{"key":"2026051911001200200_ljag058-B22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/JCAS.JCAS_75_18","article-title":"Cross-sectional study of dermatoscopic findings in relation to activity in vitiligo: BPLeFoSK criteria for stability","volume":"12","author":"Nirmal","year":"2019","journal-title":"J Cutan Aesthet Surg"},{"key":"2026051911001200200_ljag058-B23","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1111\/jocd.14922","article-title":"Differentiating active from stable vitiligo: the role of dermoscopic findings and their relation to CXCL10","volume":"21","author":"Ibrahim","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026051911001200200_ljag058-B24","doi-asserted-by":"crossref","first-page":"1112811","DOI":"10.3389\/fimmu.2023.1112811","article-title":"A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes","volume":"14","author":"Speeckaert","year":"2023","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1346-8138.14004","article-title":"Role of chemokines and the corresponding receptors in vitiligo: a pilot study","volume":"45","author":"Yang","year":"2018","journal-title":"J Dermatol"},{"key":"2026051911001200200_ljag058-B26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann Dermatol"},{"key":"2026051911001200200_ljag058-B28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00403-024-03182-y","article-title":"Ritlecitinib, a JAK3\/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo","volume":"316","author":"Yamaguchi","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B29","doi-asserted-by":"crossref","first-page":"1468665","DOI":"10.3389\/fimmu.2025.1468665","article-title":"Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jdermsci.2018.12.005","article-title":"Circulating CCL20: a potential biomarker for active vitiligo together with the number of Th1\/17 cells","volume":"93","author":"Zhang","year":"2019","journal-title":"J Dermatol Sci"},{"key":"2026051911001200200_ljag058-B31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and interleukin-6 are reliable serum markers for vitiligo activity: a multicenter cross-sectional study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.5858\/arpa.2025-0099-OA","article-title":"Evaluating Interferon \u03b3 to interleukin 10 ratio as a biomarker for stability and severity in vitiligo: a clinical and histopathologic correlation","volume":"149","author":"Bhuyan","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"2026051911001200200_ljag058-B33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cyto.2016.12.014","article-title":"Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo","volume":"91","author":"Bhardwaj","year":"2017","journal-title":"Cytokine"},{"key":"2026051911001200200_ljag058-B34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","article-title":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","volume":"424","author":"Tembhre","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2026051911001200200_ljag058-B35","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/jocd.14612","article-title":"Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity","volume":"21","author":"Mahmoud Marie","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026051911001200200_ljag058-B36","doi-asserted-by":"crossref","first-page":"6952299","DOI":"10.1155\/2022\/6952299","article-title":"Meta-analysis of alterations in regulatory T cells\u2019 frequency and suppressive capacity in patients with vitiligo","volume":"2022","author":"Giri","year":"2022","journal-title":"J Immunol Res"},{"key":"2026051911001200200_ljag058-B37","doi-asserted-by":"crossref","first-page":"e12598","DOI":"10.1111\/dth.12598","article-title":"The expression change of ROR\u03b3t, BATF, and IL-17 in Chinese vitiligo patients with 308 nanometers excimer laser treatment","volume":"31","author":"Wang","year":"2018","journal-title":"Dermatol Ther"},{"key":"2026051911001200200_ljag058-B38","first-page":"e208","article-title":"Interleukin-17 level in patients with vitiligo: a systematic review and meta-analysis","volume":"61","author":"Acharya","year":"2020","journal-title":"Australas J Dermatol"},{"key":"2026051911001200200_ljag058-B39","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLOS ONE"},{"key":"2026051911001200200_ljag058-B40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ijd.17627","article-title":"Segmental vitiligo: autoimmune pathogenesis, neuronal mechanisms, and somatic mosaicism","volume":"64","author":"Lin","year":"2025","journal-title":"Int J Dermatol"},{"key":"2026051911001200200_ljag058-B41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B43","doi-asserted-by":"crossref","first-page":"145409","DOI":"10.1155\/2015\/145409","article-title":"Decreased circulating T regulatory cells in Egyptian patients with nonsegmental vitiligo: correlation with disease activity","volume":"2015","author":"Hegab","year":"2015","journal-title":"Dermatol Res Pract"},{"key":"2026051911001200200_ljag058-B44","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/ijd.17959","article-title":"Regulatory T cell dysregulation in vitiligo: a meta-analysis and systematic review of immune mechanisms and therapeutic perspectives","volume":"64","author":"Lerner","year":"2025","journal-title":"Int J Dermatol"},{"key":"2026051911001200200_ljag058-B45","first-page":"8265","article-title":"Soluble CD27 and MIF as possible serum biomarkers of vitiligo activity in Egyptian patients in Sharkia Governorate","volume":"11","author":"ElGhareeb","journal-title":"Dermatol Rep"},{"key":"2026051911001200200_ljag058-B46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jamadermatol.2016.2366","article-title":"Clinical significance of serum soluble CD molecules to assess disease activity in vitiligo","volume":"152","author":"Speeckaert","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2026051911001200200_ljag058-B47","doi-asserted-by":"crossref","first-page":"1069196","DOI":"10.3389\/fimmu.2022.1069196","article-title":"Circulatory levels of alarmins in patients with non-segmental vitiligo: potential biomarkers for disease diagnosis and activity\/severity assessment","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B48","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jid.2017.01.033","article-title":"S100B is a potential disease activity marker in nonsegmental vitiligo","volume":"137","author":"Speeckaert","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00403-024-03765-9","article-title":"The role of serum S100B and serum thyroid stimulating hormone levels in vitiligo","volume":"317","author":"Shetty","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/0019-5154.143506","article-title":"Can systemically generated reactive oxygen species help to monitor disease activity in generalized vitiligo? A pilot study","volume":"59","author":"Pradhan","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2026051911001200200_ljag058-B51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","article-title":"Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo","volume":"117","author":"Dell'Anna","year":"2001","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00403-006-0680-2","article-title":"A comparative study of oxidant\u2013antioxidant status in stable and active vitiligo patients","volume":"298","author":"Ines","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B53","doi-asserted-by":"crossref","first-page":"739413","DOI":"10.3389\/fcell.2021.739413","article-title":"Clinical significance of serum oxidative stress markers to assess disease activity and severity in patients with non-segmental vitiligo","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026051911001200200_ljag058-B54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0019-5154.177764","article-title":"Serum homocysteine and total antioxidant status in vitiligo: a case control study in Indian population","volume":"61","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol"},{"key":"2026051911001200200_ljag058-B55","doi-asserted-by":"crossref","first-page":"27425","DOI":"10.1038\/s41598-025-11448-2","article-title":"Clinical, histological, and immunohistochemical signatures of non-segmental vitiligo: a case\u2013control analysis of Melan-A expression and CD8+ T-cell infiltration","volume":"15","author":"\u00d6zg\u00fcn Ge\u00e7er","year":"2025","journal-title":"Sci Rep"},{"key":"2026051911001200200_ljag058-B56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/DAD.0000000000000539","article-title":"Clinicopathologic analysis of stable and unstable vitiligo: a study of 66 cases","volume":"38","author":"Yadav","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"2026051911001200200_ljag058-B57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","article-title":"Type I interferon signature in the initiation of the immune response in vitiligo","volume":"27","author":"Bertolotti","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaci.2019.10.036","article-title":"Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026051911001200200_ljag058-B59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.12691","article-title":"Inflammasome activation and vitiligo\/nonsegmental vitiligo progression","volume":"170","author":"Marie","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/15569527.2011.560913","article-title":"Tumor necrosis factor-\u03b1 in vitiligo: direct correlation between tissue levels and clinical parameters","volume":"30","author":"Kim","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"2026051911001200200_ljag058-B61","doi-asserted-by":"crossref","first-page":"18298","DOI":"10.1038\/s41598-021-97296-2","article-title":"CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"2026051911001200200_ljag058-B62","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLOS ONE"},{"key":"2026051911001200200_ljag058-B63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/ijd.12160","article-title":"Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo","volume":"53","author":"Abdallah","year":"2014","journal-title":"Int J Dermatol"},{"key":"2026051911001200200_ljag058-B64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ben Ahmed","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"van Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2340\/00015555-2889","article-title":"Predictive model for response rate to narrowband ultraviolet B phototherapy in vitiligo: a retrospective cohort study of 579 patients","volume":"98","author":"Cabrera","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"2026051911001200200_ljag058-B67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2006.09.004","article-title":"Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy","volume":"56","author":"Nicolaidou","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/09546634.2018.1544409","article-title":"Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo","volume":"30","author":"Silpa-Archa","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"2026051911001200200_ljag058-B69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/pcmr.12699","article-title":"Classification of facial vitiligo: a cluster analysis of 473 patients","volume":"31","author":"Bae","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026051911001200200_ljag058-B70","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/bjd.12147","article-title":"Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy","volume":"168","author":"Benzekri","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B71","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1468-3083.2011.04215.x","article-title":"Acral lesions of vitiligo: why are they resistant to photochemotherapy?","volume":"26","author":"Esmat","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026051911001200200_ljag058-B72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1524-4725.2011.02171.x","article-title":"Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting","volume":"38","author":"Feetham","year":"2012","journal-title":"Dermatol Surg"},{"key":"2026051911001200200_ljag058-B73","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2133.2010.10148.x","article-title":"Noninvasive cutaneous blood flow as a response predictor for visible light therapy on segmental vitiligo: a prospective pilot study","volume":"164","author":"Yu","year":"2011","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B74","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051984","article-title":"Management of stable vitiligo \u2013 a review of the surgical approach","volume":"12","author":"Grochocka","year":"2023","journal-title":"J Clin Med"},{"key":"2026051911001200200_ljag058-B75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaad.2022.07.021","article-title":"Treatment outcomes and prognostic factors of motorized 0.5-mm micropunch grafting with a skin-seeding technique for 83 cases of vitiligo in children","volume":"88","author":"Kim","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B76","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaad.2018.06.016","article-title":"Motorized 0.8-mm micropunch grafting for refractory vitiligo: a retrospective study of 230 cases","volume":"79","author":"Bae","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/idoj.idoj_297_24","article-title":"Treatment of vitiligo associated eyebrow and eyelash leukotrichia \u2013 a systematic review of existing information","volume":"16","author":"Biswas","year":"2025","journal-title":"Indian Dermatol Online J"},{"key":"2026051911001200200_ljag058-B78","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.xjidi.2023.100230","article-title":"Baseline levels of circulating inflammatory biomarkers stratify patients with vitiligo who significantly repigment after treatment with ruxolitinib cream","volume":"3","author":"Howell","year":"2023","journal-title":"JID Innov"},{"key":"2026051911001200200_ljag058-B79","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jid.2023.03.1689","article-title":"Lesional CD8+ T-cell number predicts surgical outcomes of melanocyte\u2013keratinocyte transplantation surgery for vitiligo","volume":"143","author":"Refat","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B80","doi-asserted-by":"crossref","first-page":"e60254","DOI":"10.1371\/journal.pone.0060254","article-title":"Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients\u2019 autologous melanocytes transplantation efficiency","volume":"8","author":"Zhou","year":"2013","journal-title":"PLOS ONE"},{"key":"2026051911001200200_ljag058-B81","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jid.2020.12.021","article-title":"The role of CXCL10 and IL-18 as markers of repigmentation response in nonsegmental vitiligo treated with narrowband UVB phototherapy: a prospective cohort study","volume":"141","author":"Hojman","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B82","doi-asserted-by":"crossref","first-page":"872458","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-\u03b3 signatures and granzyme B as useful biomarker for activity, severity and prognosis assessment in vitiligo","volume":"13","author":"Ng","year":"2022","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B83","doi-asserted-by":"crossref","first-page":"613031","DOI":"10.3389\/fimmu.2021.613031","article-title":"Vitiligo skin biomarkers associated with favorable therapeutic response","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"2026051911001200200_ljag058-B84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00403-022-02348-w","article-title":"Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy","volume":"315","author":"Youssef","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B85","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/phpp.12362","article-title":"Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo","volume":"34","author":"El-Hanbuli","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026051911001200200_ljag058-B86","doi-asserted-by":"crossref","first-page":"761562","DOI":"10.3389\/fmolb.2022.761562","article-title":"Urinary proteomics analysis of active vitiligo patients: biomarkers for steroid treatment efficacy prediction and monitoring","volume":"9","author":"Qian","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2026051911001200200_ljag058-B87","doi-asserted-by":"crossref","first-page":"e15099","DOI":"10.1111\/dth.15099","article-title":"Dermatoscopic assessment of treatment response in patients undergoing autologous non-cultured epidermal cell suspension for the treatment of stable vitiligo: a prospective study","volume":"34","author":"Dev","year":"2021","journal-title":"Dermatol Ther"},{"key":"2026051911001200200_ljag058-B88","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jid.2023.10.006","article-title":"Noninvasive imaging techniques for monitoring cellular response to treatment in stable vitiligo","volume":"144","author":"Shiu","year":"2024","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/ijd.ijd_11_22","article-title":"Assessment of CXCL10 before and after narrow band UVB phototherapy in non-segmental vitiligo patients","volume":"67","author":"Hussein","year":"2022","journal-title":"Indian J Dermatol"},{"key":"2026051911001200200_ljag058-B90","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome","volume":"314","author":"El-Domyati","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"Suppl. 2","key":"2026051911001200200_ljag058-B91","article-title":"Vitiligo biomarker CXCL10 correlates with clinical response in the phase 2 randomized, double-blind, vehicle-controlled TRuE-V mechanism of action study","volume":"191","author":"Passeron","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/phpp.12719","article-title":"Altered circulating memory T cells in vitiligo cases followed NB-UVB therapy","volume":"38","author":"Lin","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026051911001200200_ljag058-B93","doi-asserted-by":"crossref","first-page":"2479567","DOI":"10.1080\/09546634.2025.2479567","article-title":"The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial","volume":"36","author":"Guo","year":"2025","journal-title":"J Dermatolog Treat"},{"key":"2026051911001200200_ljag058-B94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jid.2025.07.029","article-title":"Immune and biological changes during treatment in patients with non-segmental vitiligo and their relation to repigmentation","volume":"146","author":"Ouwerkerk","year":"2026","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/exd.12369","article-title":"T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp Dermatol"},{"key":"2026051911001200200_ljag058-B96","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/jid.2015.126","article-title":"Narrow Band ultraviolet B treatment for human vitiligo is associated with proliferation, migration, and differentiation of melanocyte precursors","volume":"135","author":"Goldstein","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B97","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jdv.12647","article-title":"Vitiligo: characterization of melanocytes in repigmented skin after punch grafting","volume":"29","author":"Kovacs","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026051911001200200_ljag058-B98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaci.2023.09.021","article-title":"Improvements in immune\/melanocyte biomarkers with JAK3\/TEC family kinase inhibitor ritlecitinib in vitiligo","volume":"153","author":"Guttman-Yassky","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2026051911001200200_ljag058-B99","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1590\/abd1806-4841.20187589","article-title":"Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq","volume":"93","author":"Ocampo-Candiani","year":"2018","journal-title":"An Bras Dermatol"},{"key":"2026051911001200200_ljag058-B100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00403-020-02068-z","article-title":"Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study","volume":"313","author":"Gauthier","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B101","doi-asserted-by":"crossref","first-page":"111779","DOI":"10.1016\/j.mad.2023.111779","article-title":"Acceleration of melanocyte senescence by the proinflammatory cytokines IFN\u03b3 and TNF\u03b1 impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy","volume":"211","author":"Dong","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"2026051911001200200_ljag058-B102","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1590\/S0100-879X2012007500152","article-title":"Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris","volume":"46","author":"Ma","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"2026051911001200200_ljag058-B103","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","article-title":"Levels of TGF-\u03b2(1) in serum and culture supernatants of CD4 + CD25+ T cells from patients with non-segmental vitiligo","volume":"303","author":"Tu","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B104","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/idoj.idoj_386_23","article-title":"Serum granulysin as a possible key marker of vitiligo activity and severity","volume":"15","author":"Mustafa","year":"2024","journal-title":"Indian Dermatol Online J"},{"key":"2026051911001200200_ljag058-B105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population","volume":"169","author":"Dwivedi","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B106","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2018.08.029","article-title":"Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: a systematic review and meta-analysis","volume":"80","author":"Tsai","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026051911001200200_ljag058-B107","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2147\/CCID.S372112","article-title":"Differential expression of serum exosomal Hsa-miR-487b-3p in progressive vitiligo before and after systemic corticosteroid treatment","volume":"15","author":"Luo","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026051911001200200_ljag058-B108","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cdd.2015.117","article-title":"Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo","volume":"23","author":"Shi","year":"2016","journal-title":"Cell Death Differ"},{"key":"2026051911001200200_ljag058-B109","doi-asserted-by":"crossref","first-page":"e23648","DOI":"10.1002\/jcla.23648","article-title":"Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance","volume":"35","author":"Zhang","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"2026051911001200200_ljag058-B110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 chemotactic signals in vitiligo onset and progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2026051911001200200_ljag058-B111","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0019-5154.185704","article-title":"Heat shock protein-70 expression in vitiligo and its relation to the disease activity","volume":"61","author":"Doss","year":"2016","journal-title":"Indian J Dermatol"},{"key":"2026051911001200200_ljag058-B112","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00403-025-03801-2","article-title":"Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients","volume":"317","author":"Elgarhy","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"2026051911001200200_ljag058-B113","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0781.2011.00643.x","article-title":"A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo","volume":"28","author":"El-Zawahry","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026051911001200200_ljag058-B114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","article-title":"Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo","volume":"139","author":"Chen","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"2026051911001200200_ljag058-B115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026051911001200200_ljag058-B116","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/s41598-020-75135-0","article-title":"Urinary metabolomic investigations in vitiligo patients","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"2026051911001200200_ljag058-B117","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/bjd\/ljaf079","article-title":"Proteomic analysis of plasma and urine for efficacy prediction biomarkers of Janus kinase inhibitors combined with phototherapy in vitiligo","volume":"192","author":"Hu","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026051911001200200_ljag058-B118","doi-asserted-by":"crossref","first-page":"e15177","DOI":"10.1111\/exd.15177","article-title":"Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses","volume":"33","author":"Peeva","year":"2024","journal-title":"Exp Dermatol"},{"key":"2026051911001200200_ljag058-B119","doi-asserted-by":"crossref","first-page":"107098","DOI":"10.1016\/j.imlet.2025.107098","article-title":"Immunological features driving distinct repigmentation patterns in patients with stable vitiligo submitted to the autologous keratinocyte\/melanocyte transplantation","volume":"277","author":"Frias","year":"2025","journal-title":"Immunol Lett"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag058\/66967461\/ljag058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/6\/1006\/66967461\/ljag058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/6\/1006\/66967461\/ljag058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:00:29Z","timestamp":1779202829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/6\/1006\/8489163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,18]]},"published-print":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag058","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,2,18]]}}}